Daily Tablet

    Foundayo (Orforglipron)

    A once-daily oral GLP-1 tablet, taken without the food and water restrictions required by some other oral GLP-1 treatments.

    From £185/month

    Assessed and prescribed remotely where appropriate, with medication delivered to your home.

    Medically reviewed by Dr Chris Herman, GMC 2376587
    Last reviewed 5 September 2026

    What Is Foundayo?

    Foundayo (orforglipron) is a once-daily oral GLP-1 receptor agonist. Unlike some other oral GLP-1 tablets, it is a small-molecule medicine that does not require the strict fasting or water-timing rules some patients find inconvenient.

    As with all GLP-1 treatments, dosing starts low and is increased gradually under clinical supervision.

    Available strengths: 0.8mg–17.2mg. Your clinician will determine the appropriate starting dose and escalation schedule for you.

    How It Works

    • Reduces appetite
    • Increases feelings of fullness
    • Slows gastric emptying

    Who May Be Suitable

    Treatment may be considered for adults who:

    • Have a BMI within a clinically defined range
    • Have weight-related health conditions (such as hypertension or type 2 diabetes), or
    • Meet other medical criteria set out in UK guidance
    • Prefer a tablet without strict food and water timing requirements

    A full medical history is required before any prescribing decision is made. We do not prescribe for cosmetic weight loss.

    How It's Administered

    • Taken once daily as a tablet, at any time of day
    • Can be taken with or without food, and without the water-timing restrictions required by some other oral GLP-1 medicines
    • Swallowed whole with a normal glass of water
    • Dose is increased gradually over time under clinical supervision

    Who Should Not Use This Treatment

    Treatment is unlikely to be suitable if you:

    • Are pregnant, breastfeeding, or trying to conceive
    • Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
    • Have a known hypersensitivity to orforglipron or any other ingredient in Foundayo
    • Have type 1 diabetes or a history of diabetic ketoacidosis
    • Have a history of pancreatitis or severe gastrointestinal disease (this will be reviewed individually)

    This is not a complete list. Your clinician will review your full history during assessment.

    Common Side Effects

    • Nausea, vomiting, or diarrhoea
    • Constipation or indigestion
    • Abdominal pain or bloating
    • Reduced appetite
    • Fatigue or headache

    Serious Warning Signs

    Seek urgent medical attention if you experience:

    • Severe, persistent abdominal pain (possibly spreading to your back), with or without vomiting — may indicate pancreatitis
    • Pain in the upper right abdomen, fever, or yellowing of the skin or eyes — may indicate a gallbladder problem
    • Swelling of the face, lips, tongue, or throat, or difficulty breathing — signs of a severe allergic reaction
    • A lump or swelling in the neck, hoarseness, or difficulty swallowing — should be reported promptly
    • Signs of dehydration or kidney problems following prolonged vomiting or diarrhoea

    Monitoring We Provide

    • An initial clinical assessment covering your medical history, weight, BMI, and relevant health conditions
    • Scheduled clinical reviews before each dose increase to check tolerability and progress
    • Ongoing access to message our clinical team between appointments
    • Periodic review of your weight, side effects, and overall suitability to continue treatment

    If You Want To Stop

    • You can stop treatment at any time — there is no obligation to continue
    • We recommend telling your prescribing clinician so they can advise on stopping safely
    • Clinical trial evidence shows weight regain is common after stopping GLP-1 treatment, so your clinician can discuss a plan for maintaining results
    • Your subscription can be paused or cancelled in line with our cancellation policy

    Cost, Prescription & Delivery

    • From £185/month, including your prescription, medication, and ongoing clinical support
    • Medication is dispensed by a UK-regulated pharmacy and delivered in discreet packaging
    • Pricing may vary by dose as your treatment is titrated — your clinician will confirm costs at each stage
    • No long-term contract — you can pause or cancel your subscription at any time

    Frequently Asked Questions

    About Foundayo

    Dosage & Administration

    Impact & Side Effects

    Common side effects of GLP-1 medicines may include nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and reduced appetite. Treatment outcomes vary between individuals and weight loss is not guaranteed. Foundayo is prescription-only and offered following clinical assessment.

    Ready to find out if Foundayo is right for you?

    Complete our online suitability check and our GP-led clinical team will personally review your information.